Abstract
Low lignan status has been reported to be related to an elevated risk of breast cancer. Since lignan status is reduced by antibacterial medications, it is plausible to hypothesize that repeated use of antibiotics may also be a risk factor for breast cancer. History of treatment for urinary tract infection was studied for its prediction of breast cancer among 9461 Finnish women 19–89 years of age and initially cancer-free. During a follow-up in 1973–1991, a total of 157 breast cancer cases were diagnosed. Women reporting previous or present medication for urinary tract infection at baseline showed an elevated breast cancer risk in comparison with other women. The age-adjusted relative risk was 1.34 (95% confidence interval (CI) = 0.98–1.83). The association was concentrated to women under 50 years of age. The relative risk for these women was 1.74 (95% CI 1.13–2.68), whereas it was 0.97 (95% CI 0.59–1.58) for older women. The relative risk in the younger age-group was 1.47 (95% CI 0.73–2.97) during the first 10 years of follow-up, and 1.93 (95% CI 1.11–3.37) for follow-up times longer than 10 years. These data suggest that premenopausal women using long-term medication for urinary tract infections show a possible elevated risk of future breast cancer. The results are, however, still inconclusive and the hypothesis needs to be tested by other studies. © 2000 Cancer ResearchCampaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adlercreutz H (1998) Human health and phytoestrogens. In: Reproductive and Development Toxicology, Korach KD (ed), pp. 299–371. Marcel Dekker: New York
Adlercreutz H and Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29: 95–120
Adlercreutz H, Fotsis T, Bannwart C, Wähälä K, Mäkelä T, Brunow G and Gorbach SL (1986) Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 25: 791–797
Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR and Gorbach SL (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet ii: 1295–1299
Barnett BJ and Stephens DS (1997) Urinary tract infection: an interview. Am J Med Sci 314: 245–249
Borriello SP, Setchell KD, Axelson M and Lawson AM (1985) Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 58: 37–43
Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc B 34: 187–220
Harris JR, Lippman ME, Veronesi U and Willett W (1992) Breast cancer. N Engl J Med 327: 319–328
Hulten K, Winkwist A, Adlercreutz H, Lenner P, Johansson R and Hallmans G (1998). A prospective study on lignans and breast cancer. The Cost 916 Workshop on Phyto-oestrogens: exposure, bioavailability, health benefits and safety concerns, Doorwerth, The Netherlands, 17–18 April
Ingram D, Sanders K, Kolybaba M and Lopez D (1998) Case–control study of phyto-oestrogens and breast cancer. Lancet 350: 990–994
Knekt P, Marniemi J, Teppo L, Heliövaara M and Aromaa A (1998) Is low selenium status a risk factor for lung cancer?. Am J Epidemiol 148: 975–982
Setchell KD, Lawson AM, Borriello SP, Harkness R, Gordin H, Morgan DM, Kirk DN, Adlercreutz H, Anderson LC and Axelson M (1981) Lignan formation in man–microbial involvement and possible roles in relation to cancer. Lancet ii: 4–7
Teppo L, Pukkala E and Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experiences in Finland. Acta Oncol 33: 365–369
World Health Organization (1955) International Classification of Diseases. Manual of international statistical classification of diseases, injuries, and causes of death, 7th Revision. World Health Organization: Geneva
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Knekt, P., Adlercreutz, H., Rissanen, H. et al. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?. Br J Cancer 82, 1107–1110 (2000). https://doi.org/10.1054/bjoc.1999.1047
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1047
Keywords
This article is cited by
-
Meeresalgen: auch für Europäerinnen protektiv?
gynäkologie + geburtshilfe (2017)
-
Maternal use of antibiotics and cancer in the offspring: results of a case–control study in Germany
Cancer Causes & Control (2010)
-
Association between Antibiotic use Prior to Breast Cancer Diagnosis and Breast Tumour Characteristics (United States)
Cancer Causes & Control (2006)
-
Use of antibiotics and risk of breast cancer: a population-based case–control study
British Journal of Cancer (2005)
-
Antibiotic exposure and breast cancer in New Zealand
Breast Cancer Research and Treatment (2005)